Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Thyroid Disease”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableLooking for participantsNCT07072143
What this trial is testing

An International Study on Pediatric Patients With Rare Tumors.

Who this might be right for
Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more
Azienda Ospedaliera di Padova 6,250
Not applicableStudy completedNCT00480428
What this trial is testing

Radiation Exposure and Thyroid Disease in Kazakhstan

Who this might be right for
Thyroid CancerThyroid NodulesOther Thyroid Disease
National Cancer Institute (NCI) 117
Not applicableStudy completedNCT00339716
What this trial is testing

Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident

Who this might be right for
Thyroid CancerNon-Cancer Thyroid DiseaseNon Thyroid Cancer
National Cancer Institute (NCI) 19,456
Not applicableUnknownNCT05628506
What this trial is testing

Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples

Who this might be right for
Thyroid
Prof. Gerasimos Sykiotis 20
Not applicableStudy completedNCT02989103
What this trial is testing

Hyperthyroid Follow-Up Study

Who this might be right for
All-Cause MortalityCirculatory and Other Disease MortalityThyroid and Other Cancer Mortality
National Cancer Institute (NCI) 35,593
Early research (Phase 1)Active Not RecruitingNCT05241834
What this trial is testing

LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

Who this might be right for
Carcinoma, Non-Small-Cell LungThyroid Neoplasms
Eli Lilly and Company 70
Not applicableStudy completedNCT06227819
What this trial is testing

BVA-200 vs BVA-100 Validation Study

Who this might be right for
Heart FailureHigh Blood PressureHigh Cholesterol+7 more
Daxor Corporation 62
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00048334
What this trial is testing

Depsipeptide to Treat Thyroid and Other Advanced Cancers

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 28
Not applicableLooking for participantsNCT06324578
What this trial is testing

Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease

Who this might be right for
SjögrenAutoimmune Thyroid Disease
IRCCS Burlo Garofolo 150
Not applicableEnrolling By InvitationNCT06583395
What this trial is testing

Quest to Analyze One Thousand Humans Meditating

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Angina, StableAnxiety+52 more
Tobias Moeller-Bertram 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081
What this trial is testing

Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

Who this might be right for
Solid TumorMedullary Thyroid Cancer
Eli Lilly and Company 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Not applicableStudy completedNCT04418570
What this trial is testing

Hormonal and Inflammatory Biomarkers and Response to Cognitive Remediation in Recent-onset Psychosis

Who this might be right for
Psychotic Disorders
Corporacion Parc Tauli 28
Early research (Phase 1)Active Not RecruitingNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 155
Not applicableNot Yet RecruitingNCT06730971
What this trial is testing

This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure

Who this might be right for
Thyroid Cancer
Asmaa Mohamed Emam 300
Early research (Phase 1)WithdrawnNCT02915172
What this trial is testing

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT03435952
What this trial is testing

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Who this might be right for
Malignant Neoplasm of BreastMalignant Neoplasms of Digestive OrgansMalignant Neoplasms of Eye Brain and Other Parts of Central Nervous System+9 more
M.D. Anderson Cancer Center 18
Not applicableStudy completedNCT00580203
What this trial is testing

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

Who this might be right for
Head and Neck Cancers
Memorial Sloan Kettering Cancer Center 1,468
Testing effectiveness (Phase 2)Study completedNCT02383927
What this trial is testing

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Who this might be right for
Thyroid CancerSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)HRAS Mutant Tumor+1 more
Kura Oncology, Inc. 63
Load More Results